{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T17:55:12Z","timestamp":1790013312366,"version":"4.0.1"},"reference-count":32,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,25]],"date-time":"2024-09-25T00:00:00Z","timestamp":1727222400000},"content-version":"am","delay-in-days":390,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R34DA046598"],"award-info":[{"award-number":["R34DA046598"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","japha.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Pharmacists Association"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.japh.2023.05.001","type":"journal-article","created":{"date-parts":[[2023,5,4]],"date-time":"2023-05-04T11:54:27Z","timestamp":1683201267000},"page":"1521-1529.e3","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Naloxone analogy and opioid overdose terminology preferences among rural caregivers: Differences by race"],"prefix":"10.1016","volume":"63","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5925-234X","authenticated-orcid":false,"given":"Kalynn","family":"Hosea","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8821-5636","authenticated-orcid":false,"given":"Patricia","family":"Mashburn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6470-9594","authenticated-orcid":false,"given":"Korey","family":"Kennelty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3497-0406","authenticated-orcid":false,"given":"Salisa C.","family":"Westrick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3615-9059","authenticated-orcid":false,"given":"Kevin","family":"Look","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1414-1846","authenticated-orcid":false,"given":"Donna","family":"Evon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2025-8140","authenticated-orcid":false,"given":"Delesha M.","family":"Carpenter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.japh.2023.05.001_bib2","first-page":"e6","article-title":"Opioid use disorder and COVID-19: crashing of the crises","volume":"14","author":"Khatri","year":"2020","journal-title":"J\u00a0Addict Med"},{"issue":"5","key":"10.1016\/j.japh.2023.05.001_bib3","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.dsx.2020.06.008","article-title":"COVID-19 and addiction","volume":"14","author":"Dubey","year":"2020","journal-title":"Diabetes Metab Syndr"},{"key":"10.1016\/j.japh.2023.05.001_bib4","first-page":"25","article-title":"Analgesic prescribing in the opioid overdose epidemic","author":"Dionne","year":"2018","journal-title":"NC Dental Gazette"},{"issue":"4","key":"10.1016\/j.japh.2023.05.001_bib5","doi-asserted-by":"crossref","first-page":"372","DOI":"10.3390\/v12040372","article-title":"Virology, epidemiology, pathogenesis, and control of COVID-19","volume":"12","author":"Jin","year":"2020","journal-title":"Viruses"},{"key":"10.1016\/j.japh.2023.05.001_bib6","doi-asserted-by":"crossref","first-page":"940","DOI":"10.15585\/mmwr.mm7129e2","article-title":"Vital signs: drug overdose deaths, by selected sociodemographic and social determinants of health characteristics \u2014 25 states and the District of Columbia, 2019\u20132020","volume":"71","author":"Kariisa","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"14","key":"10.1016\/j.japh.2023.05.001_bib10","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.2146\/ajhp170560","article-title":"Nonprescription availability of the opioid antagonist naloxone","volume":"75","author":"Landers","year":"2018","journal-title":"Am J Health Syst Pharm"},{"issue":"5","key":"10.1016\/j.japh.2023.05.001_bib11","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.japh.2020.03.005","article-title":"Revisiting pharmacy-based naloxone with pharmacists and naloxone consumers in 2 states: 2017 perspectives and evolving approaches","volume":"60","author":"Green","year":"2020","journal-title":"J\u00a0Am Pharm Assoc (2003)"},{"issue":"6","key":"10.1016\/j.japh.2023.05.001_bib12","doi-asserted-by":"crossref","first-page":"881","DOI":"10.2105\/AJPH.2020.305620","article-title":"Laws mandating coprescription of naloxone and their impact on naloxone prescription in five US states, 2014-2018","volume":"110","author":"Green","year":"2020","journal-title":"Am J Public Health"},{"issue":"11","key":"10.1016\/j.japh.2023.05.001_bib13","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.2105\/AJPH.2020.305868","article-title":"A\u00a0century later: rural public health's enduring challenges and opportunities","volume":"110","author":"Ziller","year":"2020","journal-title":"Am J Public Health"},{"key":"10.1016\/j.japh.2023.05.001_bib14","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.15585\/mmwr.mm6935a1","article-title":"Vital signs: characteristics of drug overdose deaths involving opioids and stimulants \u2014 24 states and the District of Columbia, January-June 2019","volume":"69","author":"O'Donnell","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.japh.2023.05.001_bib15","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.drugpo.2019.09.021","article-title":"Attitudes and availability: a comparison of naloxone dispensing across chain and independent pharmacies in rural and urban areas in Alabama","volume":"74","author":"Sisson","year":"2019","journal-title":"Int J Drug Policy"},{"issue":"1","key":"10.1016\/j.japh.2023.05.001_bib16","doi-asserted-by":"crossref","first-page":"30","DOI":"10.3390\/pharmacy9010030","article-title":"What is known about community pharmacy-based take-home naloxone programs and program interventions? A scoping review","volume":"9","author":"Cid","year":"2021","journal-title":"Pharmacy (Basel)"},{"issue":"1","key":"10.1016\/j.japh.2023.05.001_bib17","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s12954-019-0317-3","article-title":"Justice involvement patterns, overdose experiences, and naloxone knowledge among men and women in criminal justice diversion addiction treatment","volume":"16","author":"Gicquelais","year":"2019","journal-title":"Harm Reduct J"},{"issue":"3","key":"10.1016\/j.japh.2023.05.001_bib18","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s11606-016-3895-8","article-title":"Attitudes toward naloxone prescribing in clinical settings: a qualitative study of patients prescribed high dose opioids for chronic non-cancer pain","volume":"32","author":"Mueller","year":"2017","journal-title":"J\u00a0Gen Intern Med"},{"issue":"3","key":"10.1016\/j.japh.2023.05.001_bib19","doi-asserted-by":"crossref","first-page":"197","DOI":"10.2217\/pmt-2017-0065","article-title":"Prescribing naloxone for opioid overdose intervention","volume":"8","author":"Dunne","year":"2018","journal-title":"Pain Manag"},{"issue":"4S","key":"10.1016\/j.japh.2023.05.001_bib20","doi-asserted-by":"crossref","first-page":"S127","DOI":"10.1016\/j.japh.2020.12.007","article-title":"Impact of pharmacist counseling to enhance the accessibility of naloxone nasal spray to patients in a community pharmacy setting","volume":"61","author":"Napoli","year":"2021","journal-title":"J\u00a0Am Pharm Assoc (2003)"},{"issue":"1","key":"10.1016\/j.japh.2023.05.001_bib21","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1093\/jamiaopen\/ooz068","article-title":"Acceptability of smartphone applications for facilitating layperson naloxone administration during opioid overdoses","volume":"3","author":"Marcu","year":"2019","journal-title":"JAMIA Open"},{"issue":"3","key":"10.1016\/j.japh.2023.05.001_bib22","first-page":"367","article-title":"Beliefs associated with pharmacy-based naloxone: a qualitative study of pharmacy-based naloxone purchasers and people at risk for opioid overdose","volume":"96","author":"Donovan","year":"2019","journal-title":"J\u00a0Urban Health"},{"key":"10.1016\/j.japh.2023.05.001_bib23","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.drugpo.2017.09.015","article-title":"'I have it just in case' - naloxone access and changes in opioid use behaviours","volume":"51","author":"Heavey","year":"2018","journal-title":"Int J Drug Policy"},{"key":"10.1016\/j.japh.2023.05.001_bib26","article-title":"Opioid overdose counseling and prescribing of naloxone in rural community pharmacies: a pilot study","volume":"2","author":"Teeter","year":"2021","journal-title":"Explor Res Clin Soc Pharm"},{"issue":"10","key":"10.1016\/j.japh.2023.05.001_bib27","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/j.sapharm.2017.11.011","article-title":"A\u00a0content review of online naloxone continuing education courses for pharmacists in states with standing orders","volume":"14","author":"Carpenter","year":"2018","journal-title":"Res Social Adm Pharm"},{"key":"10.1016\/j.japh.2023.05.001_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2021.103344","article-title":"Lessons learned recruiting a diverse sample of rural study participants during the COVID-19 pandemic","volume":"97","author":"Kim","year":"2021","journal-title":"Int J Drug Policy"},{"key":"10.1016\/j.japh.2023.05.001_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.cct.2022.106920","article-title":"Addressing the opioid epidemic through community pharmacy engagement: study protocol for a randomized controlled trial","volume":"121","author":"Gamble","year":"2022","journal-title":"Contemp Clin Trials"},{"key":"10.1016\/j.japh.2023.05.001_bib31","series-title":"1942. Basics of Qualitative Research: Techniques and Procedures for Developing Grounded Theory","author":"Strauss","year":"1998"},{"key":"10.1016\/j.japh.2023.05.001_bib32","series-title":"Storied Health and Illness: Communicating Personal, Cultural, & Political Complexities","author":"Yamasaki","year":"2017"},{"issue":"5","key":"10.1016\/j.japh.2023.05.001_bib33","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1016\/j.japh.2022.04.019","article-title":"North Carolina community pharmacists' buprenorphine dispensing practices and attitudes","volume":"62","author":"Carpenter","year":"2022","journal-title":"J\u00a0Am Pharm Assoc (2003)"},{"issue":"2","key":"10.1016\/j.japh.2023.05.001_bib34","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.japh.2021.10.002","article-title":"Ensuring buprenorphine access in rural community pharmacies to prevent overdoses","volume":"62","author":"Ostrach","year":"2022","journal-title":"J\u00a0Am Pharm Assoc (2003)"},{"key":"10.1016\/j.japh.2023.05.001_bib35","article-title":"Rural community pharmacist willingness to dispense Suboxone\u00ae - a secret shopper investigation in South-Central Appalachia","volume":"4","author":"Trull","year":"2021","journal-title":"Explor Res Clin Soc Pharm"},{"issue":"1","key":"10.1016\/j.japh.2023.05.001_bib36","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/s12954-021-00517-0","article-title":"Pharmacist attitudes and provision of harm reduction services in North Carolina: an exploratory study","volume":"18","author":"Parry","year":"2021","journal-title":"Harm Reduct J"},{"issue":"23","key":"10.1016\/j.japh.2023.05.001_bib37","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1056\/NEJMp1609578","article-title":"The rising price of naloxone - risks to efforts to stem overdose deaths","volume":"375","author":"Gupta","year":"2016","journal-title":"N\u00a0Engl J Med"},{"issue":"5","key":"10.1016\/j.japh.2023.05.001_bib38","doi-asserted-by":"crossref","first-page":"550","DOI":"10.5993\/AJHB.33.5.8","article-title":"Health literacy skills in rural and urban populations","volume":"33","author":"Zahnd","year":"2009","journal-title":"Am J Health Behav"},{"issue":"22","key":"10.1016\/j.japh.2023.05.001_bib39","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1056\/NEJMsa1912403","article-title":"FDA initiative for drug facts label for over-the-counter naloxone","volume":"382","author":"Cohen","year":"2020","journal-title":"N\u00a0Engl J Med"}],"container-title":["Journal of the American Pharmacists Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1544319123001413?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1544319123001413?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T05:53:31Z","timestamp":1761544411000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1544319123001413"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":32,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["S1544319123001413"],"URL":"https:\/\/doi.org\/10.1016\/j.japh.2023.05.001","relation":{},"ISSN":["1544-3191"],"issn-type":[{"value":"1544-3191","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Naloxone analogy and opioid overdose terminology preferences among rural caregivers: Differences by race","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Pharmacists Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.japh.2023.05.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 American Pharmacists Association\u00ae. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}